| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/30/2002 | US6380160 Gp130 lacking the transmembrane domain |
| 04/30/2002 | US6380159 Genes for male accessory gland proteins in drosophila melanogaster |
| 04/30/2002 | US6380158 Motilin homologs |
| 04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
| 04/30/2002 | US6380156 Having antiviral, antitumor, and immunosuppressive activities |
| 04/30/2002 | US6380155 Use of vasopressin receptor antagonist for regulation of ACTH release |
| 04/30/2002 | US6380154 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/30/2002 | US6379967 A mutant viral gene that prevents viral replication in human cells; gene therapy |
| 04/30/2002 | US6379961 Stimulating neural crest cell differentiation in culture by administering an amount of a purified bone morphogenetic protein |
| 04/30/2002 | US6379960 A nucleic acid molecule; diagnosis and therapy for breast cancer, hepatitis and alzheimer's disease |
| 04/30/2002 | US6379959 An isolated protease inhibitor; antitumor, anticarcinogenic agents |
| 04/30/2002 | US6379954 Amido and peptido modified catalytic oligonucleotides |
| 04/30/2002 | US6379953 An activated leukocyte cell adhesion molecule bearing mesenchymal stem cell; for accelerating differentiation of bone morphogenic proteins; bone repair therapy |
| 04/30/2002 | US6379951 Compounds for immunotherapy of breast cancer and methods for their use |
| 04/30/2002 | US6379950 Recombinant, active caspases and uses thereof |
| 04/30/2002 | US6379945 Gene switch |
| 04/30/2002 | US6379926 Polynucleotides encoding chemokine β-6 antagonists |
| 04/30/2002 | US6379925 Angiogenic modulation by notch signal transduction |
| 04/30/2002 | US6379923 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/30/2002 | US6379905 Fragments of prion proteins |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample |
| 04/30/2002 | US6379701 Controlled release of metal cation-stabilized interferon |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379690 A tissue engineering cell scaffold for engineering bone tissue comprising a keratin hydrogel comprising reformed keratin-to keratin disulfide links; keratin derived from human hair; nonantigenic wound healing agent |
| 04/30/2002 | US6379679 Genetic engineering; viricides |
| 04/30/2002 | US6379675 Immunological combination compositions and methods |
| 04/30/2002 | US6379674 Use of herpes vectors for tumor therapy |
| 04/30/2002 | US6379672 Prevention of infectious diseases with gp96-peptide complexes |
| 04/30/2002 | US6379671 Using a polypeptide antigen mixture |
| 04/30/2002 | US6379670 Administering a genetic engineering polypeptide |
| 04/30/2002 | US6379668 Therapy for autoimmune disease |
| 04/30/2002 | US6379667 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 04/30/2002 | US6379665 Therapy for rheumatic diseases; antiarthritic agents |
| 04/30/2002 | US6379664 Administering human lense thiotransferase inhibitor polypeptide |
| 04/30/2002 | US6379662 Human interleukin variation |
| 04/30/2002 | US6379661 Pharmaceutical compositions comprising pluripotent granulocyte colony-stimulating factor |
| 04/30/2002 | US6379654 Oral composition providing enhanced tooth stain removal |
| 04/30/2002 | US6379651 Administering and ingesting peroral tablets of an antibiotic/antibacterial compound with a bismuth compound, and chewing within oral cavity |
| 04/30/2002 | US6378526 Methods of ophthalmic administration |
| 04/30/2002 | CA2300666C Method for treating dystonia with botulinum toxin type b |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2147162C Remyelination using neural stem cells |
| 04/30/2002 | CA2093819C Platelet adhesion inhibitor |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
| 04/30/2002 | CA2054111C Novel inhibitory peptides |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/27/2002 | CA2360015A1 Angiotensin i-converting enzyme inhibitory substance |
| 04/25/2002 | WO2002033124A1 KChAP-MODULATOR OF POTASSIUM CHANNELS |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033115A2 Claspin proteins and methods of use thereof |
| 04/25/2002 | WO2002033114A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033113A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033112A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033111A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033097A2 Regulation of human sulfotransferase |
| 04/25/2002 | WO2002033096A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033090A2 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/25/2002 | WO2002033089A2 Ixodes scapularis tissue factor pathway inhibitor |
| 04/25/2002 | WO2002033087A2 Proteins and nucleic acids encoding same |
| 04/25/2002 | WO2002033085A2 Wisp polypeptides and therapeutical applications thereof |
| 04/25/2002 | WO2002033083A2 Methods of using a human il-17-related polypeptide to treat disease |
| 04/25/2002 | WO2002033080A2 Regulation of human netrin binding membrane receptor unc5h-1 |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033078A1 A novel-polypeptide, a proliferating cell antigen p120-51.59 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
| 04/25/2002 | WO2002033073A1 Degraded agonist antibody |
| 04/25/2002 | WO2002033064A1 Zipper protein kinase and uses thereof |
| 04/25/2002 | WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | WO2002033062A1 REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE |
| 04/25/2002 | WO2002033058A2 Novel cysteine proteases and uses thereof |
| 04/25/2002 | WO2002033056A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033050A2 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002033042A2 Recombinant antibody fragments as autoantibody antagonists |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032959A2 Obesity-specific g protein coupled receptors |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032957A1 Peg-modified erythropoietin |
| 04/25/2002 | WO2002032954A2 Phosphorylation modifications of apoptin |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032952A1 A novel polypeptide, a human kinesin light chain 62.92 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002032951A1 A novel polypeptide, a f-box protein 44.33 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002032950A1 A novel polypeptide-homo dna-dependent 2-hydroxy acid dehydrogenase family protein 26.29 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032949A1 A novel polypeptide-homo macro-protein 81 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032948A1 A novel polypeptide-homo macro-protein 10.12 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032942A2 Compositions and methods for modulating rsv infection and immunity |
| 04/25/2002 | WO2002032941A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/25/2002 | WO2002032940A2 Osteopontin-coated surfaces and methods of use |
| 04/25/2002 | WO2002032939A2 Secreted proteins and their uses |
| 04/25/2002 | WO2002032938A2 Regulation of human pgc-1-like protein |